Younossi ZM - Search Results

1

Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes.

Younossi ZM, Wong VW, Anstee QM, Romero-Gomez M, Trauner MH, Harrison SA, Lawitz EJ, Okanoue T, Camargo M, Kersey K, Myers RP, Goodman Z, Stepanova M. Younossi ZM, et al. Hepatol Commun. 2020 Aug 28;4(11):1637-1650. doi: 10.1002/hep4.1581. eCollection 2020 Nov. Hepatol Commun. 2020. PMID: 33163834 Free PMC article.

2

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

Poynard T, Ratziu V, McHutchison J, Manns M, Goodman Z, Zeuzem S, Younossi Z, Albrecht J. Poynard T, et al. Hepatology. 2003 Jul;38(1):75-85. doi: 10.1053/jhep.2003.50267. Hepatology. 2003. PMID: 12829989 Clinical Trial.

3

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.

Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM. Ong JP, et al. Among authors: younossi zm. Obes Surg. 2005 Mar;15(3):310-5. doi: 10.1381/0960892053576820. Obes Surg. 2005. PMID: 15826462

4

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

Younossi ZM, Gorreta F, Ong JP, Schlauch K, Del Giacco L, Elariny H, Van Meter A, Younoszai A, Goodman Z, Baranova A, Christensen A, Grant G, Chandhoke V. Younossi ZM, et al. Liver Int. 2005 Aug;25(4):760-71. doi: 10.1111/j.1478-3231.2005.01117.x. Liver Int. 2005. PMID: 15998427

5

A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease.

Younossi ZM, Baranova A, Ziegler K, Del Giacco L, Schlauch K, Born TL, Elariny H, Gorreta F, VanMeter A, Younoszai A, Ong JP, Goodman Z, Chandhoke V. Younossi ZM, et al. Hepatology. 2005 Sep;42(3):665-74. doi: 10.1002/hep.20838. Hepatology. 2005. PMID: 16116632

6

Depression, anemia and health-related quality of life in chronic hepatitis C.

Dan AA, Martin LM, Crone C, Ong JP, Farmer DW, Wise T, Robbins SC, Younossi ZM. Dan AA, et al. Among authors: younossi zm. J Hepatol. 2006 Mar;44(3):491-8. doi: 10.1016/j.jhep.2005.11.046. Epub 2005 Dec 27. J Hepatol. 2006. PMID: 16427157

7

Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.

Baranova A, Gowder SJ, Schlauch K, Elariny H, Collantes R, Afendy A, Ong JP, Goodman Z, Chandhoke V, Younossi ZM. Baranova A, et al. Among authors: younossi zm. Obes Surg. 2006 Sep;16(9):1118-25. doi: 10.1381/096089206778392149. Obes Surg. 2006. PMID: 16989692

8

Pathologic assessment of non-alcoholic fatty liver disease.

Bondini S, Kleiner DE, Goodman ZD, Gramlich T, Younossi ZM. Bondini S, et al. Among authors: younossi zm. Clin Liver Dis. 2007 Feb;11(1):17-23, vii. doi: 10.1016/j.cld.2007.02.002. Clin Liver Dis. 2007. PMID: 17544969 Review.

9

A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis.

Calvert VS, Collantes R, Elariny H, Afendy A, Baranova A, Mendoza M, Goodman Z, Liotta LA, Petricoin EF, Younossi ZM. Calvert VS, et al. Among authors: younossi zm. Hepatology. 2007 Jul;46(1):166-72. doi: 10.1002/hep.21688. Hepatology. 2007. PMID: 17596878

10

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N, Goodman Z, Chandhoke V, Baranova A. Younossi ZM, et al. Obes Surg. 2008 Nov;18(11):1430-7. doi: 10.1007/s11695-008-9506-y. Epub 2008 May 24. Obes Surg. 2008. PMID: 18500507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

665 results

Search Page

Filters